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Environmental risk assessments are only conducted 
on pharmaceuticals  licenced after 2006.6
At each stage of a pharmaceutical lifecycle, there is a significant risk of environmental exposure. For this reason, it is imperative to
implement both source directed and end of pipe control measures. This will mitigate any potential hazards to the environment or to
humans. The ever-increasing use and availability of pharmaceuticals in the last decade have led to the contamination of surface
water ecosystems with ng/L to µg/L concentrations. The environmental fate and toxicological implications of many pharmaceuticals
and their residues are not fully understood. Additionally, the stability and biological activity of these “micro-pollutants” can lead to
chronic environmental exposure causing behavioural and health-related effects. This research investigates pharmaceuticals chosen
from the updated surface water “Watch List” (Decision (EU) 2018/840), followed by pharmaceuticals which are commonly found in
European surface water and pharmaceuticals which have a low removal efficiency in wastewater treatment plants.1 This project
aims to create a comprehensive prioritisation framework and a risk-based assessment by calculating their risk quotient for each of
the chosen pharmaceuticals.
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Presence of Pharmaceuticals in Irish Surface Waters
Each of these chosen pharmaceuticals have been identified as Contaminants of Emerging Concern (CECs).2 However, the 
chemical cocktail of pharmaceuticals and their associated metabolites can lead to an unknown toxicity to humans and biota.
Factors influencing environmental concentrations and risk assessment
Introduction:
Life cycle of pharmaceuticals 
Pharmaceuticals commonly found in European surface waters
Erythromycin
0.8-174.73 ng/L
Clarithromycin
1.26-141 ng/L
Azithromycin
1-71.67 ng/L
Sulfamethoxazole
1.5-330 ng/L
Amoxicillin
1.16 ng/L17 α-ethinylestradiol
1.16-117 ng/L
17 β-estradiol
0.449-14.1 ng/L
Estrone
0.05-29.2 ng/L
Gemfibrozil
0.91-326 ng/L
Carbamazepine
0.2-1705 ng/L
Ciprofloxacin
1-93.3 ng/L
Diclofenac
0.5-2550 ng/L
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Aquaculture
Climate change!
Droughts and floods can drastically alter the
dilution of pharmaceuticals in surface water. This
can lead to pollution events where the toxic
effects of pharmaceuticals are heightened.572%
of 398 people questioned 
in Cork and Galway had 
said they have improperly 
disposed of medicine in 
the past.5
Pharmaceutical usage is 
projected to increase by 
43-67 percent by the year 
2045. 4
Water Framework Directive priority chemical
Water Framework Directive watch list chemicals
CECs with low removal efficiency
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Trimethoprim
0.1-317.2 ng/L
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